QA: Axsome Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001579428_2023_Axsome_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001579428, Axsome Therapeutics Inc

  xvar xval
0 AssetsCurrent 245,641,409
1 IntangibleAssetsNetIncludingGoodwill 69,970,772
2 PropertyPlantAndEquipmentNet 722,515
3 remainder_Assets 15,141,399
4 LiabilitiesCurrent 96,560,798
5 LiabilitiesNoncurrent 94,258,888
6 remainder_Liabilities 31,100,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 211,020,265
9 ResearchAndDevelopmentExpense 58,199,289
10 remainder_Expenses 7,610,896
11 remainder_Revenues 50,037,106
12 remainder_NetIncome -5,645,189
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 331,476,095
1 Liabilities 221,919,686
2 Expenses 276,830,450
3 Revenues 50,037,106
4 StockholdersEquity 109,556,409
5 NetIncome -232,438,533
6 ComprehensiveNetIncome -232,438,533
7 BaseVar 442,954,263
8 EconomicCapitalRatiobeforeLimitedLiability 0.0231
9 EconomicCapitalRatio 1.43

Edgar->Model Mapping

Feature Distribution

Change over Time